Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Event Type
Facet Toggle
Time Frame
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 10, 2025
Takahiro Tsuda and Atsushi Mimura from the Japanese Ministry of Finance join Javier Guzman to examine current funding mechanisms for pandemic preparedness and response, explore Japan's role in driving global efforts (and insights gained), and discuss potential pathways to strengthen PPR financing.
Blog Post
February 25, 2025
Reducing access to vital treatments against drug-resistant TB will likely pose huge risks for everyone, including Americans. The 90-day freeze on most aid while this assessment is carried out causes real challenges for accessing medication. Even though waivers have been written for TB treatment and ...
Blog Post
February 13, 2025
Robert F. Kennedy Jr.’s confirmation as US secretary of health and human services comes at a critical moment for global health. To uphold and strengthen the US role in global health—and safeguard decades of progress while protecting Americans from emerging health threats—Secretary Kennedy should pri...
CGD NOTE
February 07, 2025
The political economy of global health financing is increasingly driven by fiscal constraints, geopolitical instability, and shifting power dynamics. The COVID-19 pandemic stalled or reversed health gains, and countries and donors now face tightening budgets and rising debt repayments, threatening t...
Blog Post
January 31, 2025
In grocery stores across the US, shoppers buying eggs face soaring prices—or empty shelves—amid an outbreak of bird flu, caused by the H5N1 virus. Beyond America’s borders, Uganda just confirmed a case of Ebola in its capital Kampala; neighboring Tanzania is facing a Marburg virus outbreak; and the ...
WORKING PAPER
January 29, 2025
This study estimates the costs of four key interventions to mitigate antimicrobial resistance globally by 2050. These interventions include improving access to water, sanitation, and hygiene, enhancing childhood vaccination, developing new antibiotics, and increasing access to healthcare and existin...
WORKING PAPER
January 29, 2025
This study estimates the global inpatient healthcare costs attributable to antimicrobial resistance (AMR) and projects future expenditures across different scenarios. It finds that AMR accounts for 25.4 million hospital admissions annually, resulting in $66.4 billion in excess healthcare costs, with...
WORKING PAPER
January 29, 2025
Antimicrobial resistance (AMR) poses a major global challenge, affecting both human health and economies. This research models the potential impacts of AMR on global GDP and various sectors, showing that while better treatment and combined interventions can boost economic growth, accelerated resista...
Blog Post
January 22, 2025
In 2021 alone, AMR killed an estimated 1.14 million people annually—and if countries stick to a business-as-usual approach, it could claim 39 million lives between 2025 and 2050. Beyond the human toll, rising resistance rates could drive health costs up by US$ 325 billion and shrink the global econo...
Blog Post
December 12, 2024
Catharina Boehme, Assistant Director-General for External Relations, Partnerships, and Governance at the WHO, joins guest-host Pete Baker to discuss the outcomes of the WHO Investment Round and the opportunities and risks it presents for strengthening global health and pandemic preparedness.